Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1616 1633 1636
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19568680 | YEAST CELL WALL PARTICLE ENCAPSULATION OF BIODEGRADABLE PRO-PAYLOADS | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 17999891 | CLEAVABLE DNA-ENCODED LIBRARY | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 17822746 | EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS | Final Rejection | Genentech, Inc. |
| 18271536 | TREATING DISEASES AND IMPROVING NUCLEIC ACID DELIVERY | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18314810 | Site-Specific Gene Modifications | Final Rejection | The Regents of the University of California |
| 18553774 | NOVEL FORMS OF CYCLIC DINUCLEOTIDE COMPOUNDS | Non-Final OA | Merck Sharp & Dohme LLC |
| 17626674 | MULTILAMELLAR RNA NANOPARTICLES | Final Rejection | University of Florida Research Foundation, Inc. |
| 18698888 | LIPID NANOPARTICLES FOR DRUG DELIVERY TO MICROGLIA IN THE BRAIN | Non-Final OA | Massachusetts Institute of Technology |
| 17791504 | LONG-ACTING THERAPEUTIC AGENT COMBINATIONS AND METHODS THEREOF | Final Rejection | University of Washington |
| 18280048 | CHAPERONIN-CONTAINING TCP-1 INHIBITORS FOR THE TREATMENT OF CANCER | Non-Final OA | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. |
| 18015800 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18248988 | NOVEL LIGANDS FOR ASIALOGLYCOPROTEIN RECEPTOR | Final Rejection | SANOFI |
| 18340588 | RNAi-NANOPARTICLE CONJUGATE, COMPOSITION, AND METHOD OF SYNTHESIS THEREOF | Non-Final OA | Council of Scientific & Industrial Research |
| 17736251 | TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES | Non-Final OA | Alnylam Pharmaceuticals, Inc. |
| 17836972 | RESIDENCE STRUCTURES AND RELATED METHODS | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17914408 | A METHOD AND SYSTEM FOR INTRODUCING ONE OR MORE EXOGENOUS SUBSTANCES INTO AN IMMUNE CELL | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | Non-Final OA | Arcturus Therapeutics, Inc. |
| 18032329 | PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION | Final Rejection | FELDAN BIO INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy